10% OFF

ON THE TOTAL FEE

Input this Professional Credit at checkout for a max $30.00 offset.

FAST10

10% OFF

ON THE TOTAL FEE

Input this Professional Credit at checkout for a max $30.00 offset.

FAST10
** Fraud Prevention Notice      Be cautious of scams involving cloned emails and fake phone numbers requesting conference or journal fees. Only make payments via Science Net's official event platform and notify us immediately at [email protected] if you suspect fraud.

Hybrid Event

7th - 8th July 2026 | Calgary, Canada

International Meeting on Advances in Immunotherapy (IMA-I - 26)

Apply to Present Register as Listener
Register for Participation → View available registration categories.
4

Days

4

Hrs

07

Min

02

Sec

Call For Paper

The (IMA-I) is dedicated to advancing research excellence by bringing together leading scholars, scientists, and professionals from across the globe. It provides a platform for the dissemination of high-quality research and innovative methodologies.

With a strong focus on Immunology, the conference promotes research that contributes to academic depth, practical insights, and interdisciplinary knowledge integration.

Authors are invited to submit papers addressing, but not limited to, the following areas:

01
Innovations in immunotherapy techniques
02
Combination therapies in cancer treatment
03
Mechanisms of immune evasion by tumors
04
Role of the tumor microenvironment
05
Personalized approaches to immunotherapy
06
Adverse effects of immunotherapeutic agents
07
Immunotherapy for hematological malignancies
08
Emerging targets in cancer immunotherapy
09
Clinical trials in immunotherapy research
10
Long-term effects of immunotherapy
11
Patient selection for immunotherapy
12
Immunotherapy in solid tumors
13
Regulatory considerations for new therapies
14
Ethical issues in cancer immunotherapy
15
Role of biomarkers in treatment response
16
Innovative delivery methods for therapies
17
Impact of lifestyle on immunotherapy outcomes
18
Future of immunotherapy in oncology
19
Collaboration between research and industry
20
Global access to immunotherapy treatments

Peer Review Process

All submissions evaluated through structured peer-review to ensure academic rigor. Accepted papers may be considered for high-quality journals.

Registration Details

Secure your participation early. Limited slots are allocated on a first-come, first-served basis.

Publication Opportunities

High-quality submissions prioritized for publication in recognized journals and proceedings.

Submit Your Paper Today Register Early
2026 UPDATE

Consistent Academic Support

Science Net ensures that research activities continue without interruption in the current global situation. Participants can engage through digital and hybrid conference formats.